POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 74 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84 | -2.3% | 35,496 | -27.6% | 0.00% | 0.0% |
| Q2 2023 | $86 | +38.7% | 49,027 | +142.6% | 0.00% | +100.0% |
| Q1 2023 | $62 | -58.9% | 20,210 | -29.3% | 0.00% | -66.7% |
| Q4 2022 | $151 | -99.9% | 28,590 | -60.1% | 0.00% | -57.1% |
| Q3 2022 | $252,000 | +2420.0% | 71,587 | +4923.6% | 0.01% | – |
| Q3 2021 | $10,000 | -28.6% | 1,425 | +0.7% | 0.00% | – |
| Q2 2021 | $14,000 | +7.7% | 1,415 | +1.1% | 0.00% | – |
| Q1 2021 | $13,000 | -13.3% | 1,400 | -1.4% | 0.00% | – |
| Q4 2020 | $15,000 | – | 1,420 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 3,567,985 | $8,491,804 | 2.58% |
| Aisling Capital Management LP | 1,043,267 | $2,482,975 | 1.02% |
| Atom Investors LP | 156,168 | $371,680 | 0.08% |
| Pentwater Capital Management LP | 5,975,000 | $14,220,500 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 79,709 | $189,707 | 0.04% |
| Forefront Analytics, LLC | 24,969 | $59,428 | 0.03% |
| Callan Capital, LLC | 76,559 | $182,210 | 0.02% |
| XTX Topco Ltd | 40,782 | $97,061 | 0.02% |
| Advisory Services Network, LLC | 257,271 | $612,305 | 0.02% |
| RBF Capital, LLC | 70,171 | $167,007 | 0.01% |